Form 4: Evolent Health CEO Seth Blackley Reports Stock Transactions

Evolent Health's CEO, Seth Blackley, reports acquisition and disposal of Class A Common Stock due to vesting of restricted stock units and performance-based share units.

Summary

• On March 1, 2025, Seth Blackley, CEO of Evolent Health, had shares of Class A Common Stock withheld to satisfy tax obligations upon vesting of restricted stock units at a price of $8.99.
• On March 3, 2025, Mr. Blackley acquired 235,025 shares of Class A Common Stock through restricted stock units granted under the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• These securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028.
• Also on March 3, 2025, Mr. Blackley acquired 161,346 shares upon settlement of performance-based share units (PSUs) awarded on March 1, 2022, which vested on December 31, 2024.
• The Compensation Committee certified the achievement of specified performance metrics on March 3, 2025.
• Additionally, on March 3, 2025, 72,768 shares of Class A Common Stock were withheld to satisfy tax obligations upon settlement of these performance-based share units at a price of $8.77.
• Following these transactions, Mr. Blackley beneficially owns 706,992 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of PSUs indicates the company met performance goals, while the RSU grants align management with shareholder interests. There are no explicit negative indicators.

Positives

• The vesting of restricted stock units and settlement of performance-based share units indicate that Mr. Blackley is incentivized to improve the performance of the company.
• The vesting of performance-based share units suggests that the company has met certain performance metrics.

Future Outlook

The restricted stock units will vest over the next three years, incentivizing continued performance.

Industry Context

This filing is a routine disclosure of insider transactions, common for publicly traded companies. It provides transparency into the holdings and transactions of key executives.

Comparison to Industry Standards

• Equity compensation is a standard practice in the healthcare industry to align management's interests with those of shareholders.
• Companies like UnitedHealth Group, Humana, and CVS Health also utilize restricted stock units and performance-based incentives for their executives.
• The vesting schedules and performance metrics are typically designed to incentivize long-term value creation.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder confidence, as they demonstrate management's continued investment in the company.
• Employees may be motivated by the achievement of performance metrics that led to the PSU settlement.

Key Dates